Zheng Quan Ri Bao Zhi Sheng·2025-10-27 12:09Core Points - The company announced the approval of a proposal to sell its stock assets during the 11th Board Meeting and the first extraordinary shareholders' meeting in September 2025 [1] - The aim of the asset sale is to optimize the company's asset structure, focus on its main business, and release the value of certain assets [1] - The management is authorized to sell a total of 8,685,953 shares of Guizhou Yibai Pharmaceutical Co., Ltd., 970,605 shares of Aoyuan Optical Technology Co., Ltd., 7,716 shares of China Ping An Insurance (Group) Co., Ltd., and 4,712,205 shares of Hunan Erkang Pharmaceutical Co., Ltd. through centralized bidding, block trading, or a combination of both by December 31, 2025 [1] - The company has completed the sale of its holdings in Yibai Pharmaceutical, Aoyuan, Ping An, and Erkang Pharmaceutical [1]